We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$233M
2
WPC icon
W.P. Carey
WPC
+$93M
3
EXR icon
Extra Space Storage
EXR
+$81.4M
4
IRM icon
Iron Mountain
IRM
+$41.1M
5
EGP icon
EastGroup Properties
EGP
+$39.7M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$154M
2
KRMA
Global X Conscious Companies ETF
KRMA
+$114M
3
CUZ icon
Cousins Properties
CUZ
+$106M
4
FR icon
First Industrial Realty Trust
FR
+$66.7M
5
PSA icon
Public Storage
PSA
+$53.2M

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
1201
Novavax
NVAX
$1.21B
$2K ﹤0.01%
291
– –
PHAT icon
1202
Phathom Pharmaceuticals
PHAT
$930M
$2K ﹤0.01%
167
– –
RAPT
1203
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
– –
RGNX icon
1204
Regenxbio
RGNX
$615M
$2K ﹤0.01%
146
– –
RNG icon
1205
PUT
RingCentral
RNG
$4.77B
$2K ﹤0.01%
908
– –
RPTX
1206
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
127
– –
TARS icon
1207
Tarsus Pharmaceuticals
TARS
$2.57B
$2K ﹤0.01%
107
– –
TBPH icon
1208
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
215
– –
TVTX icon
1209
Travere Therapeutics
TVTX
$5.2B
$2K ﹤0.01%
258
– –
WVE icon
1210
Wave Life Sciences
WVE
$1.13B
$2K ﹤0.01%
349
– –
PETQ
1211
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
– –
ABOS icon
1212
Acumen Pharmaceuticals
ABOS
$165M
$1K ﹤0.01%
165
– –
ABUS icon
1213
Arbutus Biopharma
ABUS
$871M
$1K ﹤0.01%
395
– –
ALLK
1214
DELISTED
Allakos
ALLK
$1K ﹤0.01%
343
– –
ALXO icon
1215
ALX Oncology
ALXO
$268M
$1K ﹤0.01%
138
– –
AMRN
1216
Amarin Corp
AMRN
$293M
$1K ﹤0.01%
67
– –
ARQT icon
1217
Arcutis Biotherapeutics
ARQT
$3.55B
$1K ﹤0.01%
245
– –
AVIR icon
1218
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
– –
BATRK icon
1219
Atlanta Braves Holdings Series B
BATRK
$3.27B
$1K ﹤0.01%
+28
New +$1.06K
BMEA icon
1220
Biomea Fusion
BMEA
$90.4M
$1K ﹤0.01%
109
– –
CGEM icon
1221
Cullinan Oncology
CGEM
$1.07B
$1K ﹤0.01%
127
– –
CHRS icon
1222
Coherus Oncology
CHRS
$222M
$1K ﹤0.01%
262
– –
CNTA
1223
DELISTED
Centessa Pharmaceuticals
CNTA
$1K ﹤0.01%
211
– –
CRBU icon
1224
Caribou Biosciences
CRBU
$148M
$1K ﹤0.01%
176
– –
CSTL icon
1225
Castle Biosciences
CSTL
$725M
$1K ﹤0.01%
86
– –
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.